News

Internet companies are helping stoke enthusiasm for “microdosing” weight-loss drugs for wellness, mood and joint pain.
When it comes to weight loss, we’re all after a magic bullet, a simple, stress-free way of shedding the excess pounds. And so for millions around the world, the arrival of the so-called GLP-1 class of ...
GLP-1 drugs have been in the news a lot lately. Most recently, Serena Williams went public about taking GLP-1s as part of her weight loss journey. In a nutshell, GLP-1s are a trending topic—and one ...
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications. For those preferring a drug ...
The demand for weight loss drugs has skyrocketed over the past several years, but GLP1-s alone won't lead to long-term, holistic health changes for employees. GLP-1 use for overweight and obesity ...
WEST MICHIGAN — Used as treatments for type 2 diabetes, blood sugar control and weight loss, researchers are working to take the popular GLP-1 medications from being just an inject-able medication to ...
GLP-1 weight loss drugs like Ozempic and Mounjaro are booming, but their impact on gut health is raising critical questions.
Medications like Mounjaro and Wegovy are everywhere, but this GLP-1 alternative could be the cost, stress, and ...
GLP-1 weight-loss drugs are creating “mortality slippage” in life insurance which is a costly problem that's forcing insurers ...
ICER’s comparative effectiveness and value review of Wegovy, Zepbound and oral semaglutide finds they are highly effective ...
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But some researchers, payers and ...
GLP-1 drugs are expanding beyond diabetes to potentially reduce heart disease and improve sleep quality. Market for GLP-1 drugs is set to grow from $70 billion in 2025 to $157 billion by 2030, led by ...